phase (12). This suggests that p53 helps to maintain genetic In human fibroblasts, N-phosphoacetyl-L-aspartate (PALA) stability by preventing DNA replication during metabolic and γ-radiation induce reversible and irreversible p53-depletion, indicating the existence of a different p53-dependent mediated G 1 cell cycle arrest, respectively. By coupling the arrest function. premature chromosome condensation technique to fluoresPreviously, we found that, in response to γ radiation-induced cence in situ hybridization, we found no evidence of DNA DNA damage, normal human diploid fibroblasts undergo damage after PALA treatment. We used representational prolonged, probably permanent, arrest similar to senescence difference analysis (cDNA-RDA) to study changes in gene (6). In contrast, the G 1 arrest caused by PALA treatment is expression after PALA treatment and γ-radiation in normal reversible (12,13). Chromosome DNA damage, which could human fibroblasts. The mammary-derived growth inhibitor be a secondary effect, probably requires transit through S (MDGI) gene was expressed in PALA-treated cells. Ectopic phase, and is not readily observed by classic cytogenetic MDGI expression arrested PALA-treated but not irradiated analysis of such cells. These results suggest that important RKO cells. Expression of an antisense RNA against MDGI differences exist in G 1 -arrested cells following irradiation or resulted in partial G 1 escape of PALA-treated human antimetabolite treatment. fibroblasts. The tumor necrosis factor stimulated gene 6, Different genes could be expressed depending on the nature TSG-6, seems to be under the control of p53 and is of the signal (DNA damage or metabolite depletion) being only and specifically induced upon PALA treatment. In transduced to the p53-mediated arrest pathway. In PALAirradiated cells we have identified 'novel' genes that are treated cells we found no evidence of DNA damage by differentially expressed, along with known genes not previfluorescence in situ hybridization (FISH) coupled to premature ously linked to cell cycle control.
phase (12) . This suggests that p53 helps to maintain genetic In human fibroblasts, N-phosphoacetyl-L-aspartate (PALA) stability by preventing DNA replication during metabolic and γ-radiation induce reversible and irreversible p53-depletion, indicating the existence of a different p53-dependent mediated G 1 cell cycle arrest, respectively. By coupling the arrest function. premature chromosome condensation technique to fluoresPreviously, we found that, in response to γ radiation-induced cence in situ hybridization, we found no evidence of DNA DNA damage, normal human diploid fibroblasts undergo damage after PALA treatment. We used representational prolonged, probably permanent, arrest similar to senescence difference analysis (cDNA-RDA) to study changes in gene (6) . In contrast, the G 1 arrest caused by PALA treatment is expression after PALA treatment and γ-radiation in normal reversible (12, 13) . Chromosome DNA damage, which could human fibroblasts. The mammary-derived growth inhibitor be a secondary effect, probably requires transit through S (MDGI) gene was expressed in PALA-treated cells. Ectopic phase, and is not readily observed by classic cytogenetic MDGI expression arrested PALA-treated but not irradiated analysis of such cells. These results suggest that important RKO cells. Expression of an antisense RNA against MDGI differences exist in G 1 -arrested cells following irradiation or resulted in partial G 1 escape of PALA-treated human antimetabolite treatment. fibroblasts. The tumor necrosis factor stimulated gene 6, Different genes could be expressed depending on the nature TSG-6, seems to be under the control of p53 and is of the signal (DNA damage or metabolite depletion) being only and specifically induced upon PALA treatment. In transduced to the p53-mediated arrest pathway. In PALAirradiated cells we have identified 'novel' genes that are treated cells we found no evidence of DNA damage by differentially expressed, along with known genes not previfluorescence in situ hybridization (FISH) coupled to premature ously linked to cell cycle control. Some of these 'novel ' chromosome condensation (PCC). Both treatments induce genes correspond to clones in the expressed sequence tag changes in gene expression as judged by cDNA representational (EST) database; one of them shows identity with ESTs difference analysis (cDNA-RDA) (14). The expression of some mapping to a region on chromosome 7, where gene(s) of these genes in p53-defective treated cells suggests their involved in replicative senescence and frequently deleted independence from p53 trans-activation. Lack of expression in tumors are located. Thus, PALA treatment and γ-of these genes in a panel of tumor cell lines suggests a role irradiation elicit a pattern of differential gene expression in tumorigenesis. One of the newly identified genes shows that could contribute to a quiescence or senescence-like identity with expressed sequence tags (ESTs) mapping to a phenotype.
chromosomal region where gene(s) involved in replicative senescence are located and frequently deleted in tumors. Thus, PALA treatment and γ-irradiation elicit a pattern of differential Introduction gene expression that could contribute to a quiescence or The tumor suppressor p53 is an important factor for the senescence-like phenotype. maintenance of genetic stability. Ionizing radiation and chemotherapeutic drugs used in cancer treatments directly damage Materials and methods DNA and increase p53 levels, leading to arrest in the G 1 phase
Cell culture and treatments of the cell cycle or apoptosis (1) (2) (3) (4) (5) (6) . G 1 arrest is in part WS1 (normal human embryonic skin fibroblasts) cells expressing a neomycin dependent on a pathway that involves p53-dependent transcripresistance gene (WS1neo) and the HPV16 E6 protein (WS1E6), or an antisense oriented mammary-derived growth inhibitor (MDGI) cDNA fragment were tional activation of p21 WAF1/CIP1/SDI1 (7) , an inhibitor of the G 1 prepared by retroviral gene transduction and used within 12 passages after cyclin-Cdk complexes, such as cyclin D-Cdk4/Cdk6 and infection. RKO and H1299 cells expressing the MDGI full-length cDNA were cyclin E-Cdk2, which in turn inhibits phosphorylation of generated by retroviral gene transduction. Cells expressing E6 have a nonpRb (8, 9) . There is evidence that p53 can also be activated functional p53 pathway. HeLa tumor cells have no functional p53; HL60 following hypoxia in the absence of DNA damage (10) and human leukemia cells do not express p53; H1299 is a non-small cell lung carcinoma cell line lacking p53 expression due to a 5Ј intragenic deletion; may respond to metabolic signals. While many p53-responsive U2OS osteosarcoma tumor cells and RKO colorectal carcinoma cells are considered p53 wild-type. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 1ϫ non-essential amino acids Abbreviations: cDNA-RDA, cDNA representational difference analysis; EST, expressed sequence tag; FBS, fetal bovine serum; FISH, fluorescence (Gibco-BRL, Life Technologies) and 10% fetal bovine serum (FBS; Euroclone Ltd, UK) at 37°C in a humidified atmosphere containing 5% CO 2 . All cells in situ hybridization; MDGI, mammary-derived growth inhibitor; PALA, N-phosphoacetyl-L-aspartate; PCC, premature chromosome condensation.
were split 1:4, 1:6 approximately every 3 days for maintenance. Human fibroblasts synchronized in G 0 by serum deprivation were split and released Cloning of the full-length MDGI cDNA by RT-PCR in medium plus 10% dialyzed FBS and 100 µM PALA (NSC-224131) Total RNA was isolated from human placenta using the RNAeasy kit (Quiagen provided by the Drug Biosynthesis and Chemistry Branch of the National GmbH) and 2 µg were DNase treated and reverse transcribed into cDNA Cancer Institute (Bethesda, MD) for additional 72 h, or the cells were irradiated using Superscript II reverse transcriptase and oligo(dT) as a primer. cDNA (4-6 Gy) at room temperature with a 137 Cs γ-irradiator.
was used as a template in PCR reactions with the primers 5Ј-ATGGATCCAC-TATGGCGGACGCCTT-3Ј and 5Ј-GGCCTTGGATCCGCTTTATTGACC-3Ј Metaphase aberrations in order to obtain the full-length MDGI cDNA. The PCR product, after BamHI Asynchronously growing human fibroblasts were treated with PALA (100 µM) digestion, was cloned into the plasmid pGEM-t-easy (Promega), sequenced only or with PALA and caffeine (1 mM) and 2 ϫ 10 6 cells were seeded in and subcloned into the BamHI site of the retroviral vector pSLX to allow 75 cm 2 flasks. Cultures were then incubated in 0.2 µg/ml colcemid (Gibco-BRL, stable expression in infected cells. Life Technologies) for 24 h and mitotic cells were harvested. Cell swelling was induced by treatment for 10 min with 75 mM KCl at 37°C; cells were then fixed
Flow cytometric cell cycle analysis with three changes of methanol:acetic acid (3:1) and dropped on to clean iceFor experiments on asynchronous cultures, cells were seeded 24 hr prior to cold glass microscope slides. Slides were stained in 2.5% Giemsa for 10 min treatment at densities to prevent contact inhibition. Cultures were pulseand metaphase spreads were scored for chromosomal aberrations (13).
labeled with 10 µM BrdU (a thymidine analog) for 4 h 72-144 h after FISH and PCC analysis treatment, harvested and subjected to flow cytometric cell cycle analysis as previously described (6) . G 0 synchrony of WS1-asMDGI cells was achieved PCC was used to visualize chromosome damage in G 1 -arrested PALA (100 µM) by serum deprivation. For experiments on serum-deprived cultures, the FBS treated cells (15). Chinese hamster ovary (CHO) cells were used as the mitotic concentration in the medium was reduced from 10% to 0.1% for 72 h and inducer population. These cells were cultured at 37°C in a 5% CO 2 humidified cells were released in medium containing 10% FBS. BrdU (50 µM) was incubator in DMEM supplemented with 1ϫ non-essential amino acids, 1%
added at the time of release for continuous labeling of cells undergoing DNA penicillin/streptomycin and 10% FBS. Mitotic CHO cells were obtained by synthesis in the presence of PALA. Cultures were harvested and subjected to gentle shake-off following overnight incubation in medium containing flow cytometric cell cycle analysis 72 h after release as previously described 0.2 µg/ml colcemid. (6) . Data analysis was done using Cell Quest. Cellular debris and fixation Human fibroblasts were fused with mitotic CHO cells to induce chromoartifacts were gated out, and the G 0 /G 1 , S and G 2 /M fractions were quantified. somal condensation. Interphase human fibroblasts were collected by centrifugaExperiments were repeated at least twice; 10 000 events were analyzed for tion and mixed with mitotic CHO cells (ratio 1:1). The mixture was washed each sample and representative experiments are shown. twice in phosphate-buffered saline (PBS) and the pellet was resuspended in 0.1 ml/10 6 of pre-warmed polyethylene glycol (PEG) 1500 added dropwise to allow cell fusion. Following PEG dilution over a period of 10 min in Figure 2A) were used in subsequent steps of subtractive hybridization followed by PCR amplifications in order to generate the 'difference products'. Following each PCR reaction, the old adapter was removed and a new one was added using a differential hybridization signal in the 'representations' were used in northern hybridization experiments to confirm that PCC metaphases showed absence of DNA fragmentation they really corresponded to mRNA differentially expressed in revealed as additional chromosomes in these G 1 -arrested cells ( Figure 1A) . As a control, PCCs were induced in fibroblasts the treated cells ( Figure 2B ). asynchronously grown for 72 h in the presence of PALA. As Thirty-five fragments, from a total of 60 cloned into the shown in Figure 1B , the PCC technique causes chromosomal plasmid vector pUC19, gave a different hybridization signal fragmentation, revealing the presence of DNA damage that is by Southern hybridization of the 'representations' and 17 of otherwise masked. These results confirm that PALA is able to these fragments displayed a different expression pattern when keep cells in G 1 without inducing DNA damage; the presence hybridized against total RNA isolated from PALA and γ-of additional PCCs in asynchronously grown PALA-treated irradiated cells. Twelve out of the 17 positive clones were cells only reflects the fact that PALA can induce DNA damage sequenced by cycle sequencing and the resulting sequences during the S-phase transition and that some unrepaired DNA were compared (Table II) with sequences in the GenBank breaks are unmasked by the mechanical stress caused by the database. PCC technique. We concluded that DNA repair did not occur Some of the PCR fragments, derived from the cDNA-RDA in G 1 -synchronized PALA-treated cells as revealed by BrdU experiments done using the 'representation' derived from the incorporation, because of unscheduled DNA synthesis, detected PALA-treated cells as a tester, were used as probes in northern by a FITC-conjugated mouse monoclonal anti-BrdU antibody hybridization experiments, in order to assess any dependence (data not shown).
on p53 status and cell cycle position. Northern blots were Differentially expressed genes detected by cDNA-RDA in performed using total RNA isolated from WS1neo and WS1-irradiated or PALA-treated human fibroblasts E6 cells. Northern blots were also performed on total RNA isolated from tumor cells in order to assess the gene expression To investigate whether differential gene expression could be detected depending on the signal transduced to the p53-pattern. These experiments are shown in Figure 3A . Here we probed northern blots with the MDGI gene and observed a basal level of expression in asynchronous cells, which was increased in starved cells. Northern blot analysis showed that the MDGI gene was not expressed in irradiated G1-arrested influenced directly by p53 status. When the human tumor necrosis factor-inducible (TSG-6) gene was used as a probe in northern hybridization experiments, expression was only treatment. The fact that there was no expression in WS1-E6 cells suggests that this gene could be under the control of p53. observed in PALA-arrested cells. Interestingly, lack of expression was observed both in asynchronous and synchronized
The human phosphotyrosine independent ligand p62 for the p56 lck Src homology domain 2 (SH2) gene was expressed cells, indicating a specific induction of this gene upon PALA differently in PALA-treated cells than in irradiated cells.
level following MDGI over-expression showed no p53 increase in untreated RKO-MDGI cells. Also, RKO and RKO-MDGI However, expression of this gene does not seem to be under cells showed, when treated with PALA, a similar p53 increase p53 control because there is a basal level of expression in (G.Costanzo, unpublished results). Both stably transfected WS1-E6 cells. Expression of MDGI and TSG-6 genes was not H1299 (H1299-MDGI) and control H1299 cells were resistant detected in most tumor cells tested, with the exception that ( Figure 4B ) to PALA and did not arrest at the two time points HeLa cells expressed MDGI. Expression of the p62 gene was analyzed. To assess whether MDGI over-expression in RKO detected in all tumor cells. Northern analysis was also carried cells could be responsible for a generalized arrest response out on total RNA isolated from the same cells indicated above, following stressful signals, we analyzed by FACScan the cell using as a probe DNA fragments obtained from cDNA-RDA cycle progression after γ-irradiation. As shown in Figure 4C , of the representation derived from γ-irradiated cells as a tester.
it seems that MDGI participates specifically in the PALAThe plasminogen activator inhibitor (PAI-1) showed increased induced arrest pathway, because the cell cycle distribution of expression after γ-irradiation in WS1neo cells, and this was RKO-MDGI cells after treatment with 6 Gy of γ-rays was more pronounced for the band corresponding to the 3.0 kb similar to that observed for untransfected RKO cells treated transcript ( Figure 3B ). PAI-1 was not expressed after PALA in the same way. These results raise the possibility that the treatment. A similar pattern was observed in WS1-E6 cells, lack of MDGI expression could, despite the presence of normal suggesting that PAI-1 expression does not depend on p53 p53, render cells refractory to PALA-induced G 1 arrest. status. This is in contrast with a previous report suggesting
To explore this possibility further, we cloned the MDGI that the PAI-1 gene can be trans-activated by p53 (17). We fragment in the antisense orientation into the retroviral vector detected a constitutive level of PAI expression also in the p53-pSLX. The recombinant retroviral vector obtained, pSLXcontaining RKO cell line but not in the p53-containing U2OS asMDGI, was used to infect normal human fibroblasts cell line. This result suggests that, in this case, the presence (WSI). The infected cells (WS1-asMDGI) were then used to of a wild-type p53 alone is not sufficient for PAI expression.
investigate whether the presence of antisense MDGI is suffiThe eukaryotic initiation factor 4AII gene (eIF4AII) was cient to override G 1 arrest after PALA treatment. Figure 4D 
MDGI participates in PALA-induced G 1 arrest in human cells
Discussion To investigate whether the differential expression of MDGI observed after PALA treatment plays any role in the p53-Signal transduction pathways that lead to G 0 /G 1 arrest in the mediated arrest response in human cells, human MDGI cDNA presence of DNA damage appear to be similar to those or in containing the full-length coding region of MDGI was isolated the presence of depleted ribonucleotide pools (6, 12) , but there by RT-PCR, verified by sequencing and subcloned into the are subtle differences, suggesting that some unique components retroviral vector pSLX to allow stable expression in infected are involved in the two types of pathway. Here we investigate cells. To evaluate whether p53 contributes to the response whether DNA damage and metabolite depletion trigger differassociated with MDGI expression, after PALA treatment, both ent expression of genes involved in the p53-mediated arrest p53-positive (RKO) and p53-negative (H1299) cells were pathway. To this end, we studied first the presence of DNA infected with recombinant retroviruses carrying the full-length damage in G 0 /G 1 -arrested PALA-treated cells by using a MDGI cDNA. As shown in Figure 4A , stably transfected combination of PCC and FISH. We did not detect DNA RKO cells (RKO-MDGI) showed a marked reduction in the damage in G 0 /G 1 -arrested PALA-treated cells. These results are proportion of S-phase cells when treated with PALA, with consistent with what we and others have observed previously by the majority of the cells arrested in G 1 and G 2 /M both at 72
FACScan analysis (6, 12) . Some of the asynchronous PALAh and 144 h. In contrast, untransfected control cells (RKO) treated cells arrested in G2 could have some unrepaired and cells transfected with empty vector alone (RKO-pSLX) DNA breaks (single strand breaks) that are unmasked by did not arrest in G 1 and cell progression in presence of PALA unprogrammed chromosomal condensation as revealed by PCC resulted in increased mortality of these cells as revealed by an analysis. Indeed, PALA does not seem to induce persistent increasing number of cells with a sub-G 1 content of DNA.
chromosomal damage that could account for the cell cycle Such apoptotic cells made up Ͼ80% of the population for arrest as revealed by the use of the repair inhibitor caffeine in RKO cells and~60% for RKO-pSLX cells at 144 h. These asynchronous NHF3 cells. results suggest that ectopic MDGI expression in arresting cells, We then investigated, using the cDNA-RDA method (14), in response to PALA, could protect them from undergoing whether metabolite depletion or DNA damage can trigger apoptosis. Interestingly, the RKO-MDGI cells recovered from differential expression of genes involved in the p53-mediated the arrest when PALA was removed, suggesting that MDGI, arrest in human fibroblasts. Using this approach we were able when ectopically expressed in these cells, participates in to identify differentially expressed genes following different stress signals. Some of these genes, which are expressed in transient arrest. Western experiments to assess the p53 protein arrested cells by serum deprivation, seem to be involved in and 2.2 kb PAI-1 transcripts when compared with control cells. However, this increase, which was higher for the 3.0 kb the maintenance of cells in the G 1 phase of the cell cycle following PALA treatment.
transcript, could reflect a senescent-like status because of p53 overexpression in these cells, rather than being linked to The MDGI gene is a putative tumor suppressor, involved in the differentiation of breast cells, that is able to slow cell p53 directly. Our results showing that PAI-1 is expressed in p53-deficient (WS1-E6) cells following irradiation do not growth when overexpressed in cells derived from breast cancer (18). The MDGI gene is a candidate for response to a metabolic support the idea that accumulation of cellular p53 could directly affect PAI-1 expression. Interestingly, PAI-1 transcripsignal in that it suppresses the mitogenic effects of epidermal growth factor (19). Our findings that MDGI over-expression tion was elevated in late passages (senescent) of human fibroblasts (24) principally for the 3.0 kb mRNA form, and in in RKO cells results in G 1 arrest, after PALA treatment, suggest a role for the MDGI gene in p53-mediated G 1 arrest.
young fibroblasts in which two cyclin-dependent inhibitors, p16 Ink4a and p21 WAF1/CIP1/SDI1 , were ectopically expressed (25) . This arrest is likely to be p53 dependent because it was not observed in p53-deficient H1299 cells infected with the same Senescent cells, similarly to irradiated fibroblasts, appear irreversibly arrested in the G 1 phase, therefore PAI-1 increased recombinant retroviruses harboring the full-length MDGI cDNA. The observed G 1 arrest in RKO-MDGI cells appeared transcription could be considered a marker of the senescentlike phenotype suggested for irradiated fibroblasts (6) . PAI-1 to be transient, disappearing upon removal of PALA, suggesting activation of the p53-dependent checkpoint responsible for the is known to be induced by a transforming growth factor β (TGFβ) signaling pathway probably mediated by Smad proarrest induced by ribonucleotide depletion (12) .
The involvement of the MDGI gene in the PALA-induced teins. Phosphorylation of Smad3 by a TGFβ receptor is believed to be an essential step in signal transduction by TGFβ arrest pathway is stressed by our findings that some (27%) of the normal human (WS1) fibroblasts infected with the for the activation of the PAI-1 promoter. Overexpression of Smad protein combinations can mimic the transcriptional effect recombinant retrovirus harboring the MDGI fragment in the antisense orientation escaped arrest after PALA treatment. The of TGFβ on the PAI-1 promoter (26). In addition, dominantnegative Smad3 reduces the stimulation of PAI-1 (27). Eukaryfact that we observed a similar increase in the p53 protein level in RKO and RKO-MDGI PALA-treated cells, together otic initiation factor 4AII is a 407 aa factor that is required for mRNA binding to ribosomes. It has been characterized as with the observation that only RKO-MDGI cells were able to arrest in G 1 , strongly suggests that MDGI could work upstream an RNA-dependent ATPase and RNA helicase belonging to a family of RNA helicases termed DEAD box proteins. The of p53 or in cooperation with p53 in the PALA-induced G 1 arrest. murine eIF4AII gene is preferentially expressed in organs with low proliferative capacity. eIF4AII mRNA levels increased The p62 gene was also differentially expressed. This gene encodes a phosphotyrosine-independent ligand of the SH2~3-fold in cells synchronized by nutrient starvation, whereas eIF4AI mRNA levels, which are 10-fold more abundant than domain of the tyrosine kinase p56 lck , a member of the c-Src family of cytoplasmic tyrosine kinases (20). Binding of p62 eIF4AII in growing cells, remained unchanged (28). This suggests that eIF4AII mRNA synthesis is associated preferto the SH2 domain of p56 lck could prevent the catalytic activity of this tyrosine kinase affecting downstream transducers and, entially with the growth-arrested state of the cell. Overcoming the G 1 growth arrest due to senescence could in turn, cellular progression. In addition, p62 has been suggested to belong to a class of ubiquitin-binding proteins, thereby be a critical and essential step in the development of human cancer. Senescence could be then considered a major tumoraffecting a signal transduction pathway through ubiquitination and protein degradation (21). As we have shown (Figure 3) , suppressing mechanism that the cell activates to avoid tumorigenesis. In addition to already characterized genes, we have MDGI and p62 expression appear to be independent of p53. On the other hand, TSG-6 seems to be under the direct control identified two novel genes (corresponding to fragments 55 and 57) that are characterized by a different pattern of expression of p53, given its lack of expression in p53-deficient (WS1-E6) cells. In addition, TSG-6 mRNA was not detected in in irradiated cells. Fragment 57 shows high homology with one EST cluster that maps to a region on chromosome 7 that untreated cells but was readily induced by PALA in normal human fibroblasts. TSG-6 was originally identified as a tumor is deleted in some tumors and whose expression restores a cellular senescence-like behavior in immortalized human necrosis factor/interleukin-1-inducible gene (22) and has a potent anti-inflammatory activity along as well as inhibiting fibroblasts (29,30). Its functional characterization may shed light on its involvement in the regulation of senescence-like protease action (23). We speculate that the product of TSG-6 could, like PAI-1, inhibit the plasmin/plasminogen pathway. cellular mechanisms involved in tumor development. Our results suggest that expression of genes other than those PAI-1 was differentially expressed in γ-irradiated cells although its expression is probably not under the direct control directly trans-activated by p53 are necessary to maintain cells arrested in G 1 . In particular, the MDGI gene is a new candidate of p53 (Figure 3) . Previous in vitro studies (17) suggested that p53 binds to the PAI-1 promoter; overexpression of a for involvement in the transient cell cycle arrest observed in PALA-treated cells. The PAI-1 and eIF4AII genes, as well as temperature-sensitive mutant human p53, at the permissive temperature of 32.5°C, resulted in an increase in both the 3.0 the novel gene corresponding to fragment 57 participating in 
